Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 14

1.

A model-based motion capture marker location refinement approach using inverse kinematics from dynamic trials.

Price MA, LaPrè AK, Johnson RT, Umberger BR, Sup FC 4th.

Int J Numer Method Biomed Eng. 2020 Jan;36(1):e3283. doi: 10.1002/cnm.3283. Epub 2019 Nov 19.

PMID:
31721456
2.

Dynamic optimization of Gait with a Generalized Lower-Limb Prosthesis Model.

Price MA, Umberger BR, Sup FC.

IEEE Int Conf Rehabil Robot. 2019 Jun;2019:734-739. doi: 10.1109/ICORR.2019.8779532.

PMID:
31374718
3.

Design Optimization in Lower Limb Prostheses: A Review.

Price MA, Beckerle P, Sup FC.

IEEE Trans Neural Syst Rehabil Eng. 2019 Aug;27(8):1574-1588. doi: 10.1109/TNSRE.2019.2927094. Epub 2019 Jul 5.

PMID:
31283485
4.

Administration options for pegfilgrastim prophylaxis: patient and physician preferences from a cross-sectional survey.

Brett Hauber A, Mange B, Price MA, Wolin D, Bensink M, Kaye JA, Chandler D.

Support Care Cancer. 2018 Jan;26(1):251-260. doi: 10.1007/s00520-017-3841-2. Epub 2017 Aug 7.

PMID:
28785862
5.

Quantifying the relative importance to patients of avoiding symptoms and outcomes of heart failure.

Hauber AB, Obi EN, Price MA, Whalley D, Chang CL.

Curr Med Res Opin. 2017 Nov;33(11):2027-2038. doi: 10.1080/03007995.2017.1355782. Epub 2017 Aug 4.

PMID:
28704074
6.

Mortality and Causes of Death in Patients with Sporadic Inclusion Body Myositis: Survey Study Based on the Clinical Experience of Specialists in Australia, Europe and the USA.

Price MA, Barghout V, Benveniste O, Christopher-Stine L, Corbett A, de Visser M, Hilton-Jones D, Kissel JT, Lloyd TE, Lundberg IE, Mastaglia F, Mozaffar T, Needham M, Schmidt J, Sivakumar K, DeMuro C, Tseng BS.

J Neuromuscul Dis. 2016 Mar 3;3(1):67-75.

7.

"Same-Day" administration of pegfilgrastim following myelosuppressive chemotherapy: clinical practice and provider rationale.

Marion S, Tzivelekis S, Darden C, Price MA, Sherif B, Garcia J, Kaye JA, Chandler D.

Support Care Cancer. 2016 Sep;24(9):3889-96. doi: 10.1007/s00520-016-3193-3. Epub 2016 Apr 23.

PMID:
27108262
8.

Discovery of 6-Amino-2-{[(1S)-1-methylbutyl]oxy}-9-[5-(1-piperidinyl)pentyl]-7,9-dihydro-8H-purin-8-one (GSK2245035), a Highly Potent and Selective Intranasal Toll-Like Receptor 7 Agonist for the Treatment of Asthma.

Biggadike K, Ahmed M, Ball DI, Coe DM, Dalmas Wilk DA, Edwards CD, Gibbon BH, Hardy CJ, Hermitage SA, Hessey JO, Hillegas AE, Hughes SC, Lazarides L, Lewell XQ, Lucas A, Mallett DN, Price MA, Priest FM, Quint DJ, Shah P, Sitaram A, Smith SA, Stocker R, Trivedi NA, Tsitoura DC, Weller V.

J Med Chem. 2016 Mar 10;59(5):1711-26. doi: 10.1021/acs.jmedchem.5b01647. Epub 2016 Feb 10.

PMID:
26861551
9.

Cognitive interviewing in risk minimization survey development: patient and healthcare professional surveys.

DiBenedetti DB, Price MA, Andrews EB.

Expert Rev Clin Pharmacol. 2013 Jul;6(4):369-73. doi: 10.1586/17512433.2013.811824. Review.

PMID:
23927665
10.

Successful implementation of cognitive interviews in special populations.

DeMuro CJ, Lewis SA, DiBenedetti DB, Price MA, Fehnel SE.

Expert Rev Pharmacoecon Outcomes Res. 2012 Apr;12(2):181-7. doi: 10.1586/erp.11.103. Review.

PMID:
22458619
11.

Development, reliability, and validity of a new Preference and Satisfaction Questionnaire.

Gold DT, Horne R, Coon CD, Price MA, Borenstein J, Varon SF, Satram-Hoang S, Macarios D.

Value Health. 2011 Dec;14(8):1109-16. doi: 10.1016/j.jval.2011.06.010. Epub 2011 Oct 1.

12.

2,5-diketopiperazines as potent, selective, and orally bioavailable oxytocin antagonists. 3. Synthesis, pharmacokinetics, and in vivo potency.

Borthwick AD, Davies DE, Exall AM, Hatley RJ, Hughes JA, Irving WR, Livermore DG, Sollis SL, Nerozzi F, Valko KL, Allen MJ, Perren M, Shabbir SS, Woollard PM, Price MA.

J Med Chem. 2006 Jul 13;49(14):4159-70.

PMID:
16821776
13.

Potential urinary and plasma biomarkers of peroxisome proliferation in the rat: identification of N-methylnicotinamide and N-methyl-4-pyridone-3-carboxamide by 1H nuclear magnetic resonance and high performance liquid chromatography.

Ringeissen S, Connor SC, Brown HR, Sweatman BC, Hodson MP, Kenny SP, Haworth RI, McGill P, Price MA, Aylott MC, Nunez DJ, Haselden JN, Waterfield CJ.

Biomarkers. 2003 May-Aug;8(3-4):240-71.

PMID:
12944176
14.

Supplemental Content

Loading ...
Support Center